Royal Bank Of Canada Vyne Therapeutics Inc. Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $4.91 $15 - $633	129 Added 20.0%	774 $0
Q3 2022 Nov 14, 2022	BUY	$0.24 - $4.27 $149 - $2,655	622 Added 2704.35%	645 $0
Q2 2022 Aug 15, 2022	SELL	$0.37 - $0.71 $127 - $244	-344 Reduced 93.73%	23 $0
Q1 2022 May 16, 2022	SELL	$0.5 - $1.15 $191 - $440	-383 Reduced 51.07%	367 $0
Q4 2021 Feb 14, 2022	SELL	$0.91 - $1.5 $422 - $696	-464 Reduced 38.22%	750 $1,000
Q3 2021 Nov 15, 2021	SELL	$1.39 - $3.47 $3,566 - $8,904	-2,566 Reduced 67.88%	1,214 $1,000
Q2 2021 Aug 16, 2021	BUY	$3.24 - $6.92 $12,247 - $26,157	3,780 New	3,780 $13,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $176M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.